FDA Approved: LAMICTAL XR — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved Lamictal XR (lamotrigine) in an original application by GlaxoSmithKline LLC, establishing the extended-release formulation for its approved uses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• LAMICTAL XR (lamotrigine)

Snippet

ORIG AP for LAMICTAL XR (LAMOTRIGINE)